Insights from 2023 ESMO Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 ESMO Annual Meeting

Breast
Gastrointestinal
Genitourinary
Gynecologic
Skin
Sarcoma
Lung
Head and Neck
CNS

Playback speed

10 seconds

ESMO 2023 Insights: "SWOG S1801 - Pathologic Response & Exploratory Analyses of Neoadjuvant-Adjuvant vs. Adjuvant Pembro for Resectable Stage 3B/4 Melanoma"

By Insights from 2023 ESMO Annual Meeting FEATURING Sapna Patel

172 views

November 13, 2023

Comments 0

Skin

ESMO 2023 Insights: "Brain Metastases & Survival Evaluation in the S…

Insights from 2023 ESMO Annual Meeting

P. Ascierto

143 views

ESMO 2023 Insights: "CheckMate 238 Trial - Adjuvant Nivo vs. Ipi in …

Insights from 2023 ESMO Annual Meeting

P. Ascierto

94 views

ESMO 2023 Insights: "OS in Patients With Metastatic BRAF V600-Mutant…

Insights from 2023 ESMO Annual Meeting

G. In

73 views

ESMO 2023 Summary: "Where Are We Going in Uveal, Mucosal & Advanced …

Insights from 2023 ESMO Annual Meeting

O. Hamid

195 views

ESMO 2023 Insights: "SWOG S1801 - Pathologic Response & Exploratory …

Insights from 2023 ESMO Annual Meeting

S. Patel

172 views

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC …

Insights from 2023 ESMO Annual Meeting

N. Gross

193 views

ESMO 2023 Insights: "Concurrent Intrathecal and Intravenous Nivo for…

Insights from 2023 ESMO Annual Meeting

I. Glitza Oliva

131 views

ESMO 2023 Insights: "Safety & Efficacy of Low-Dose Ipi + Pembro in C…

Insights from 2023 ESMO Annual Meeting

I. Glitza Oliva

54 views

ESMO 2023 Insights: "Treatment Personalization in Advanced Melanoma"

Insights from 2023 ESMO Annual Meeting

L. Hoeijmakers

91 views

ESMO 2023 Insights: "A Surgeon’s Perspective - Do We Still Need Mela…

Insights from 2023 ESMO Annual Meeting

A. van Akkooi

65 views

ESMO 2023 Insights: "ctDNA Reduction and Clinical Efficacy of the Da…

Insights from 2023 ESMO Annual Meeting

M. McKean

64 views

ESMO 2023 Insights: "mRNA-4157 (V940) Individualized Neoantigen Ther…

Insights from 2023 ESMO Annual Meeting

J. Weber

193 views

ESMO 2023 Insights: "NIBIT-M2 Trial 7-Year Outcomes and QoL of Nivol…

Insights from 2023 ESMO Annual Meeting

A. Di Giacomo

84 views

ESMO 2023 Insights: "aTezolizumab, bevAcizumab, and Cobimetinib (TAC…

Insights from 2023 ESMO Annual Meeting

L. Burton

178 views